Patents by Inventor Pek Lum

Pek Lum has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220056434
    Abstract: This disclosure provides genomics-based methods that can be used to identify, quantify, and characterize rare cell types, including circulating tumor cells.
    Type: Application
    Filed: December 30, 2019
    Publication date: February 24, 2022
    Inventors: Christopher Armour, Pek Lum
  • Publication number: 20060240457
    Abstract: In one aspect, the present invention provides methods of determining whether an agent is more like a partial agonist of a target molecule than a full agonist of the same target molecule. In another aspect, the present invention provides methods to select a candidate compound that may reduce blood plasma glucose concentration in a mammal. Populations of genes are provided that are useful in the practice of the present invention.
    Type: Application
    Filed: April 4, 2006
    Publication date: October 26, 2006
    Applicants: Rosetta Inpharmatics LLC, Merck & Co., Inc.
    Inventors: Yejun Tan, Hongyue Dai, Pek Lum, John Thompson, Joel Berger, Eric Muise, Richard Raubertas, Kenny Wong
  • Publication number: 20050084872
    Abstract: In one aspect, the present invention provides methods for determining whether an agent (e.g., candidate drug) possesses a biological activity. In another aspect, the present invention provides populations of nucleic acid molecules useful in the practice of the present invention as probes for measuring the level of expression of populations of genes.
    Type: Application
    Filed: January 23, 2004
    Publication date: April 21, 2005
    Inventors: Pek Lum, Yejun Tan, Hongyue Dai, Eric Muise, Joel Berger, John Thompson